Статті в журналах з теми "Peptidase inhibitor 16"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Peptidase inhibitor 16".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Cwiklinski, Krystyna, Orla Drysdale, Jesús López Corrales, Yolanda Corripio-Miyar, Carolina De Marco Verissimo, Heather Jewhurst, David Smith, Richard Lalor, Tom N. McNeilly, and John P. Dalton. "Targeting Secreted Protease/Anti-Protease Balance as a Vaccine Strategy against the Helminth Fasciola hepatica." Vaccines 10, no. 2 (January 20, 2022): 155. http://dx.doi.org/10.3390/vaccines10020155.
Повний текст джерелаBai, T. R., and A. M. Bramley. "Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi." American Journal of Physiology-Lung Cellular and Molecular Physiology 264, no. 5 (May 1, 1993): L425—L430. http://dx.doi.org/10.1152/ajplung.1993.264.5.l425.
Повний текст джерелаMartínez-Guitián, Marta, Juan C. Vázquez-Ucha, Joshua Odingo, Tanya Parish, Margarita Poza, Richard D. Waite, German Bou, David W. Wareham, and Alejandro Beceiro. "Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii." Antimicrobial Agents and Chemotherapy 60, no. 7 (May 2, 2016): 4375–79. http://dx.doi.org/10.1128/aac.00510-16.
Повний текст джерелаLupsa, Nikolett, Barbara Érsek, Andor Horváth, András Bencsik, Eszter Lajkó, Pálma Silló, Ádám Oszvald, et al. "Skin‐homing CD8 + T cells preferentially express GPI‐anchored peptidase inhibitor 16, an inhibitor of cathepsin K." European Journal of Immunology 48, no. 12 (November 9, 2018): 1944–57. http://dx.doi.org/10.1002/eji.201847552.
Повний текст джерелаLin, Kun-Der, Chao-Hung Chen, Hsing-Yi Lin, Mei-Yueh Lee, Yu-Li Lee, Wei-Wen Hung, He-Jiun Jiang, Pi-Jung Hsiao, and Shyi-Jang Shin. "Dipeptidyl peptidase-4 inhibitor prevents diabetic nephropathy through STRA6 signaling." Diabetes Research and Clinical Practice 120 (October 2016): S61. http://dx.doi.org/10.1016/s0168-8227(16)31050-6.
Повний текст джерелаApaijai, Nattayaporn, Tharnwimol Inthachai, Suree Lekawanvijit, Siriporn C. Chattipakorn, and Nipon Chattipakorn. "Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction." Journal of Endocrinology 229, no. 3 (June 2016): 245–58. http://dx.doi.org/10.1530/joe-16-0096.
Повний текст джерелаRegn, Michael, Bernhard Laggerbauer, Claudia Jentzsch, Deepak Ramanujam, Andrea Ahles, Sonja Sichler, Julia Calzada-Wack, et al. "Peptidase inhibitor 16 is a membrane-tethered regulator of chemerin processing in the myocardium." Journal of Molecular and Cellular Cardiology 99 (October 2016): 57–64. http://dx.doi.org/10.1016/j.yjmcc.2016.08.010.
Повний текст джерелаDIN, KHUZMA, AMIZA MAT AMIN, FISAL AHMAD, AMIN ISMAIL, and ADAWIYAH SURIZA SHUIB. "IN SILICO ANALYSIS OF EDIBLE BIRD’S NEST PROTEINS AS POTENTIAL PRECURSORS FOR BIOACTIVE PEPTIDES." Malaysian Applied Biology 51, no. 2 (June 29, 2022): 53–62. http://dx.doi.org/10.55230/mabjournal.v51i2.1997.
Повний текст джерелаChen, Q., Y. Miao, and K. Jiang. "Peptidase Inhibitor 16 Promote Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma via Oligoadenylate Synthetase L." HPB 24 (2022): S258. http://dx.doi.org/10.1016/j.hpb.2022.05.542.
Повний текст джерелаDanilov, Alexey V., Olga V. Danilova, Andreas K. Klein, and Brigitte T. Huber. "Dipeptidyl Peptidase 2 - A Pro-Survival Molecule in Chronic Lymphocytic Leukemia." Blood 108, no. 11 (November 16, 2006): 4964. http://dx.doi.org/10.1182/blood.v108.11.4964.4964.
Повний текст джерелаDeng, Mengqing, Shuo Yang, Yue Ji, Yan Lu, Ming Qiu, Yanhui Sheng, Wei Sun, and Xiangqing Kong. "Overexpression of peptidase inhibitor 16 attenuates angiotensin II–induced cardiac fibrosis via regulating HDAC1 of cardiac fibroblasts." Journal of Cellular and Molecular Medicine 24, no. 9 (March 30, 2020): 5249–59. http://dx.doi.org/10.1111/jcmm.15178.
Повний текст джерелаPapazafiropoulou, Athanasia, Nikolaos Papanas, Aikaterini Trikkalinou, Evaggelos Fousteris, and Andreas Melidonis. "The Oral Dipeptidyl-Peptidase-4 Inhibitor Sitagliptin Increases Circulating Levels Of Stromal-Derived Factor-1 Alpha." Experimental and Clinical Endocrinology & Diabetes 126, no. 06 (September 20, 2017): 367–70. http://dx.doi.org/10.1055/s-0043-118748.
Повний текст джерелаGibbs, Gerard M., Kim Roelants, and Moira K. O'Bryan. "The CAP Superfamily: Cysteine-Rich Secretory Proteins, Antigen 5, and Pathogenesis-Related 1 Proteins—Roles in Reproduction, Cancer, and Immune Defense." Endocrine Reviews 29, no. 7 (December 1, 2008): 865–97. http://dx.doi.org/10.1210/er.2008-0032.
Повний текст джерелаFukunishi, Shinya, Akira Asai, Yasuhiro Tsuda, and Kazuhide Higuchi. "Su1966 Sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, Can Be Effective Drug for Hepatic Iron Metabolism." Gastroenterology 150, no. 4 (April 2016): S601. http://dx.doi.org/10.1016/s0016-5085(16)32065-0.
Повний текст джерелаLamango, N. S., and R. E. Isaac. "Identification and properties of a peptidyl dipeptidase in the housefly, Musca domestica, that resembles mammalian angiotensin-converting enzyme." Biochemical Journal 299, no. 3 (May 1, 1994): 651–57. http://dx.doi.org/10.1042/bj2990651.
Повний текст джерелаGROSE, RANDALL H., DEBORAH J. MILLARD, CHRIS MAVRANGELOS, SIMON C. BARRY, HEDDY ZOLA, IAN C. NICHOLSON, WENG TARNG CHAM, CHRISTINA A. BOROS, and DOREEN KRUMBIEGEL. "Comparison of Blood and Synovial Fluid Th17 and Novel Peptidase Inhibitor 16 Treg Cell Subsets in Juvenile Idiopathic Arthritis." Journal of Rheumatology 39, no. 10 (August 15, 2012): 2021–31. http://dx.doi.org/10.3899/jrheum.111421.
Повний текст джерелаHazell, Georgina, Jack E. Teasdale, Graciela Sala-Newby, Andrew C. Newby, and Stephen J. White. "Shear stress and inflammation modulate the expression of Peptidase Inhibitor 16 (PI16) in human coronary artery endothelial cells (HCAECs)." Atherosclerosis 237, no. 2 (December 2014): e8-e9. http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.056.
Повний текст джерелаMohandas, Arunesh, Heddy Zola, Simon Barry, and Doreen Krumbiegel. "Peptidase inhibitor 16 identifies a unique subset of memory T helper cells with hyperproliferative and proinflammatory properties (IRC8P.477)." Journal of Immunology 192, no. 1_Supplement (May 1, 2014): 190.5. http://dx.doi.org/10.4049/jimmunol.192.supp.190.5.
Повний текст джерелаХлебникова, Н. Н., С. Д. Ширенова, and Н. А. Крупина. "Neonatal action of the dipeptidyl peptidase iv inhibitor diprotin A leads to a hyperactive phenotype formation and a prolonged increase in aggressiveness in rats." Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia», no. 4 (December 28, 2021): 4–16. http://dx.doi.org/10.25557/0031-2991.2021.04.4-16.
Повний текст джерелаEl-Ouaghlidi, Andrea, Erika Rehring, Jens J. Holst, Anja Schweizer, James Foley, David Holmes, and Michael A. Nauck. "The Dipeptidyl Peptidase 4 Inhibitor Vildagliptin Does Not Accentuate Glibenclamide-Induced Hypoglycemia but Reduces Glucose-Induced Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide Secretion." Journal of Clinical Endocrinology & Metabolism 92, no. 11 (November 1, 2007): 4165–71. http://dx.doi.org/10.1210/jc.2006-1932.
Повний текст джерелаHarada, Masaru, Akitoshi Yoneda, Sanehito Haruyama, Kei Yabuki, Yuichi Honma, Masaaki Hiura, Michihiko Shibata, Hidehiko Matsuoka, and Yasuhiro Uchiwa. "Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma." Internal Medicine 56, no. 18 (2017): 2471–74. http://dx.doi.org/10.2169/internalmedicine.8703-16.
Повний текст джерелаWu, Tongzhi, Xiang Zhang, Laurence G. Trahair, Michelle J. Bound, Tanya J. Little, Carolyn F. Deacon, Michael Horowitz, Karen L. Jones, and Christopher K. Rayner. "Small Intestinal Glucose Delivery Affects the Lowering of Blood Glucose by Acute Vildagliptin in Type 2 Diabetes." Journal of Clinical Endocrinology & Metabolism 101, no. 12 (September 6, 2016): 4769–78. http://dx.doi.org/10.1210/jc.2016-2813.
Повний текст джерелаFujiwara, Kaori, Naoki Yorifuji, Sadaharu Nouda, Kazuki Kakimoto, Toshihiko Okada, Ken Kawakami, Toshihisa Takeuchi, Takuya Inoue, and Kazuhide Higuchi. "Su1926 Long-Term Treatment With a Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Intestinal Tumors in Models of Diabetes and Obesity." Gastroenterology 150, no. 4 (April 2016): S591. http://dx.doi.org/10.1016/s0016-5085(16)32025-x.
Повний текст джерелаAndres, Julia, Jia Xuan Yeo, and Chin Meng Khoo. "To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus." Diabetes Research and Clinical Practice 120 (October 2016): S123—S124. http://dx.doi.org/10.1016/s0168-8227(16)31232-3.
Повний текст джерелаVan Raalte, Daniël H., Renate E. van Genugten, Björn Eliasson, Diane L. Möller-Goede, Andrea Mari, Andrea Tura, Craig Wilson та ін. "The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes". European Journal of Endocrinology 170, № 4 (квітень 2014): 565–74. http://dx.doi.org/10.1530/eje-13-0639.
Повний текст джерелаDubé, Michael P., Ellen S. Chan, Jordan E. Lake, Brett Williams, Jennifer Kinslow, Alan Landay, Robert W. Coombs, Michelle Floris-Moore, Heather J. Ribaudo, and Kevin E. Yarasheski. "A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection." Clinical Infectious Diseases 69, no. 7 (December 10, 2018): 1165–72. http://dx.doi.org/10.1093/cid/ciy1051.
Повний текст джерелаErvinna, Nasib, Tomoya Mita, Eisuke Yasunari, Kosuke Azuma, Rica Tanaka, Satoshi Fujimura, Dewi Sukmawati, et al. "Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice." Endocrinology 154, no. 3 (March 1, 2013): 1260–70. http://dx.doi.org/10.1210/en.2012-1855.
Повний текст джерелаOe, Yuki, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, et al. "Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study." Journal of Diabetes Research 2022 (January 19, 2022): 1–9. http://dx.doi.org/10.1155/2022/5603864.
Повний текст джерелаBouchkouj, Najat, Shannon Larabee, Haying Qin, Joanna Louise Meadors, Crystal L. Mackall, and Terry J. Fry. "Dipeptidyl Peptidase Inhibition Alters Myeloid Derived Suppressor Cell Phenotype and Induces Regression of Pediatric Sarcomas." Blood 116, no. 21 (November 19, 2010): 3792. http://dx.doi.org/10.1182/blood.v116.21.3792.3792.
Повний текст джерелаBatchu, Sri Nagarjun, Veera Ganesh Yerra, Youan Liu, Suzanne L. Advani, Thomas Klein, and Andrew Advani. "The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans." International Journal of Molecular Sciences 21, no. 16 (August 11, 2020): 5756. http://dx.doi.org/10.3390/ijms21165756.
Повний текст джерелаLiu, Lili, Zhuo Shao, Ying Xia, Jiabi Qin, Yang Xiao, Zhiguang Zhou, and Zubing Mei. "Incretin-based therapies for patients with type 1 diabetes: a meta-analysis." Endocrine Connections 8, no. 3 (March 2019): 277–88. http://dx.doi.org/10.1530/ec-18-0546.
Повний текст джерелаTan, Xin, Na Liu, Min Yang, Mojie Duan, and Jun Zeng. "Design of peptide inhibitors of human papillomavirus 16 (HPV16) transcriptional regulator E1–E2 formation." Journal of Theoretical and Computational Chemistry 16, no. 03 (April 4, 2017): 1750026. http://dx.doi.org/10.1142/s0219633617500262.
Повний текст джерелаHuang, Po-Kai, Shi-Xiang Lin, May-Jywan Tsai, Max Leong, Shian-Ren Lin, Ranjith Kankala, Chia-Hung Lee, and Ching-Feng Weng. "Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice." Nanomaterials 7, no. 5 (May 12, 2017): 112. http://dx.doi.org/10.3390/nano7050112.
Повний текст джерелаOkura, Y., T. Namisaki, R. Noguchi, K. Takeda, K. Moriya, M. Kitade, N. Nishimura, et al. "Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis." Journal of Hepatology 64, no. 2 (2016): S582. http://dx.doi.org/10.1016/s0168-8278(16)01066-7.
Повний текст джерелаGlorie, Lorenzo, Geert J. Behets, Lesley Baerts, Ingrid De Meester, Patrick C. D'Haese, and Anja Verhulst. "DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats." American Journal of Physiology-Endocrinology and Metabolism 307, no. 5 (September 1, 2014): E447—E455. http://dx.doi.org/10.1152/ajpendo.00217.2014.
Повний текст джерелаDanilov, Alexey V., Olga Danilova, Andreas Klein, Jennifer Brown, Arthur P. Rabinowitz, Kenneth B. Miller, and Brigitte T. Huber. "ZAP-70 Disrupts Dipeptidyl Peptidase 2 (DPP2)-Regulated Quiescence in Chronic Lymphocytic Leukemia (CLL)." Blood 114, no. 22 (November 20, 2009): 1251. http://dx.doi.org/10.1182/blood.v114.22.1251.1251.
Повний текст джерелаTanajak, Pongpan, Hiranya Pintana, Natthaphat Siri-Angkul, Juthamas Khamseekaew, Nattayaporn Apaijai, Siriporn C. Chattipakorn, and Nipon Chattipakorn. "Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats." Journal of Endocrinology 232, no. 2 (February 2017): 189–204. http://dx.doi.org/10.1530/joe-16-0406.
Повний текст джерелаAngwin, Catherine, Caroline Jenkinson, Angus Jones, Christopher Jennison, William Henley, Andrew Farmer, Naveed Sattar, et al. "TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol." BMJ Open 10, no. 12 (December 2020): e042784. http://dx.doi.org/10.1136/bmjopen-2020-042784.
Повний текст джерелаXiaoying, Liu, Shawndeep Tung, Tetsuro Setoyama, Lucilla D’Abundo, Robinson Simon, Hui Yang, Eric Yvon, et al. "FOXP3 Is a Direct Target Of miR15a/16 in Umbilical Cord Blood Regulatory T Cells." Blood 122, no. 21 (November 15, 2013): 3261. http://dx.doi.org/10.1182/blood.v122.21.3261.3261.
Повний текст джерелаKasukawa, Hiroaki, Peter M. Howley, and John D. Benson. "A Fifteen-Amino-Acid Peptide Inhibits Human Papillomavirus E1-E2 Interaction and Human Papillomavirus DNA Replication In Vitro." Journal of Virology 72, no. 10 (October 1, 1998): 8166–73. http://dx.doi.org/10.1128/jvi.72.10.8166-8173.1998.
Повний текст джерелаLin, S., X. Gu, F. Wang, and W. Tan. "POS0002 PI16 REPRESSES FOXP3 EXPRESSION IN T REGULATORY CELLS AND EXACERBATES AUTOIMMUNE ARTHRITIS VIA INHIBITING THE K48-LINKED POLYUBIQUITIN DEGRADATION OF BMI-1." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 203.2–203. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2756.
Повний текст джерелаPlamboeck, Astrid, Simon Veedfald, Carolyn F. Deacon, Bolette Hartmann, André Wettergren, Lars B. Svendsen, Søren Meisner, et al. "Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty." European Journal of Endocrinology 169, no. 2 (August 2013): 187–201. http://dx.doi.org/10.1530/eje-13-0264.
Повний текст джерелаMajithia, Amit R., David M. Erani, Coco M. Kusiak, Jennifer E. Layne, Amy Armento Lee, Francis R. Colangelo, Robert J. Romanelli, et al. "Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring–Driven Virtual Care Program: Prospective Study." JMIR Formative Research 6, no. 4 (April 5, 2022): e31629. http://dx.doi.org/10.2196/31629.
Повний текст джерелаFrank, Robin, Sucheta Jagan, Lydia Luy Tan, Laura A. Paganessi, and Kent W. Christopherson. "Use of the CD26 Inhibitor Diprotin A (Ile-Pro-Ile) to Increase Mobilized Peripheral Blood Mononuclear Cell Adhesion and Migration." Blood 114, no. 22 (November 20, 2009): 372. http://dx.doi.org/10.1182/blood.v114.22.372.372.
Повний текст джерелаSidelmann Christensen, Alexander, Heidi Storgaard, Sofie Hædersdal, Torben Hansen, Filip Krag Knop, and Tina Vilsbøll. "Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial." BMJ Open 8, no. 10 (October 2018): e022517. http://dx.doi.org/10.1136/bmjopen-2018-022517.
Повний текст джерелаMcFadden, Karyn, Patricia Fletcher, Fiorella Rossi, Kantharaju, Muddagowda Umashankara, Vanessa Pirrone, Srivats Rajagopal, et al. "Antiviral Breadth and Combination Potential of Peptide Triazole HIV-1 Entry Inhibitors." Antimicrobial Agents and Chemotherapy 56, no. 2 (November 14, 2011): 1073–80. http://dx.doi.org/10.1128/aac.05555-11.
Повний текст джерелаKadarmideen, H. N., and G. Mazzoni. "Transcriptomics–genomics data integration and expression quantitative trait loci analyses in oocyte donors and embryo recipients for improving invitro production of dairy cattle embryos." Reproduction, Fertility and Development 31, no. 1 (2019): 55. http://dx.doi.org/10.1071/rd18338.
Повний текст джерелаDanilov, Alexey V., Olga V. Danilova, Andreas K. Klein, and Brigitte T. Huber. "Apoptosis in Response to Inhibition of Dipeptidyl Peptidase 2 (DPP2) Defines Low Risk Chronic Lymphocytic Leukemia (CLL)." Blood 110, no. 11 (November 16, 2007): 3094. http://dx.doi.org/10.1182/blood.v110.11.3094.3094.
Повний текст джерелаToya, Yoshiyuki, Carsten Schwencke, Jacques Couet, Michael P. Lisanti, and Yoshihiro Ishikawa. "Inhibition of Adenylyl Cyclase by Caveolin Peptides*." Endocrinology 139, no. 4 (April 1, 1998): 2025–31. http://dx.doi.org/10.1210/endo.139.4.5957.
Повний текст джерелаChintala, Sreenivasulu, Kevin Quist, and Rachel Katzenellenbogen. "Abstract 5919: Regulation of SLPI secretion by NFX1-123 and HPV 16 E6 in cervical cancer." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5919. http://dx.doi.org/10.1158/1538-7445.am2022-5919.
Повний текст джерела